1
|
Li M, Konteatis Z, Nagaraja N, Chen Y, Zhou S, Ma G, Gross S, Marjon K, Hyer ML, Mandley E, Lein M, Padyana AK, Jin L, Tong S, Peters R, Murtie J, Travins J, Medeiros M, Liu P, Frank V, Judd ET, Biller SA, Marks KM, Sui Z, Reznik SK. Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. J Med Chem 2022; 65:4600-4615. [PMID: 35293760 DOI: 10.1021/acs.jmedchem.1c01595] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Inhibition of the S-adenosyl methionine (SAM)-producing metabolic enzyme, methionine adenosyltransferase 2A (MAT2A), has received significant interest in the field of medicinal chemistry due to its implication as a synthetic lethal target in cancers with the deletion of the methylthioadenosine phosphorylase (MTAP) gene. Here, we report the identification of novel MAT2A inhibitors with distinct in vivo properties that may enhance their utility in treating patients. Following a high-throughput screening, we successfully applied the structure-based design lessons from our first-in-class MAT2A inhibitor, AG-270, to rapidly redesign and optimize our initial hit into two new lead compounds: a brain-penetrant compound, AGI-41998, and a potent, but limited brain-penetrant compound, AGI-43192. We hope that the identification and first disclosure of brain-penetrant MAT2A inhibitors will create new opportunities to explore the potential therapeutic effects of SAM modulation in the central nervous system (CNS).
Collapse
Affiliation(s)
- Mingzong Li
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Zenon Konteatis
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Nelamangala Nagaraja
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Yue Chen
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Shubao Zhou
- PharmaResources Co., Ltd., 509 Renqing Road, Pudong New Area, Shanghai 201201, China
| | - Guangning Ma
- PharmaResources Co., Ltd., 509 Renqing Road, Pudong New Area, Shanghai 201201, China
| | - Stefan Gross
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Katya Marjon
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Marc L Hyer
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Everton Mandley
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Max Lein
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Anil K Padyana
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Lei Jin
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Shuilong Tong
- Viva Biotech, Ltd., 334 Aidisheng Road, Zhangjiang High-Tech Park, Shanghai 201203, China
| | - Rachel Peters
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Joshua Murtie
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Jeremy Travins
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Matthew Medeiros
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Peng Liu
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Victoria Frank
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Evan T Judd
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Scott A Biller
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Kevin M Marks
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Zhihua Sui
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| | - Samuel K Reznik
- Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
2
|
Deger S, Greifzu F, Vohl G, Lein M. Initial experience with 3D visualization in laparoscopic radical prostatectomy. A bicentric case series. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01226-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
3
|
Trabert D, Anders N, Brennecke S, Schöffler MS, Jahnke T, Schmidt LPH, Kunitski M, Lein M, Dörner R, Eckart S. Nonadiabatic Strong Field Ionization of Atomic Hydrogen. Phys Rev Lett 2021; 127:273201. [PMID: 35061406 DOI: 10.1103/physrevlett.127.273201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Accepted: 12/07/2021] [Indexed: 06/14/2023]
Abstract
We present experimental data on the nonadiabatic strong field ionization of atomic hydrogen using elliptically polarized femtosecond laser pulses at a central wavelength of 390 nm. Our measured results are in very good agreement with a numerical solution of the time-dependent Schrödinger equation (TDSE). Experiment and TDSE show four above-threshold ionization peaks in the electron's energy spectrum. The most probable emission angle (also known as "attoclock offset angle" or "streaking angle") is found to increase with energy, a trend that is opposite to standard predictions based on Coulomb interaction with the ion. We show that this increase of deflection angle can be explained by a model that includes nonadiabatic corrections of the initial momentum distribution at the tunnel exit and nonadiabatic corrections of the tunnel exit position itself.
Collapse
Affiliation(s)
- D Trabert
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - N Anders
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - S Brennecke
- Institut für Theoretische Physik, Leibniz Universität Hannover, Appelstraße 2, 30167 Hannover, Germany
| | - M S Schöffler
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - T Jahnke
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - L Ph H Schmidt
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - M Kunitski
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - M Lein
- Institut für Theoretische Physik, Leibniz Universität Hannover, Appelstraße 2, 30167 Hannover, Germany
| | - R Dörner
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - S Eckart
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| |
Collapse
|
4
|
Kalev P, Hyer ML, Gross S, Konteatis Z, Chen CC, Fletcher M, Lein M, Aguado-Fraile E, Frank V, Barnett A, Mandley E, Goldford J, Chen Y, Sellers K, Hayes S, Lizotte K, Quang P, Tuncay Y, Clasquin M, Peters R, Weier J, Simone E, Murtie J, Liu W, Nagaraja R, Dang L, Sui Z, Biller SA, Travins J, Marks KM, Marjon K. MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage. Cancer Cell 2021; 39:209-224.e11. [PMID: 33450196 DOI: 10.1016/j.ccell.2020.12.010] [Citation(s) in RCA: 78] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Revised: 10/30/2020] [Accepted: 12/10/2020] [Indexed: 12/13/2022]
Abstract
The methylthioadenosine phosphorylase (MTAP) gene is located adjacent to the cyclin-dependent kinase inhibitor 2A (CDKN2A) tumor-suppressor gene and is co-deleted with CDKN2A in approximately 15% of all cancers. This co-deletion leads to aggressive tumors with poor prognosis that lack effective, molecularly targeted therapies. The metabolic enzyme methionine adenosyltransferase 2α (MAT2A) was identified as a synthetic lethal target in MTAP-deleted cancers. We report the characterization of potent MAT2A inhibitors that substantially reduce levels of S-adenosylmethionine (SAM) and demonstrate antiproliferative activity in MTAP-deleted cancer cells and tumors. Using RNA sequencing and proteomics, we demonstrate that MAT2A inhibition is mechanistically linked to reduced protein arginine methyltransferase 5 (PRMT5) activity and splicing perturbations. We further show that DNA damage and mitotic defects ensue upon MAT2A inhibition in HCT116 MTAP-/- cells, providing a rationale for combining the MAT2A clinical candidate AG-270 with antimitotic taxanes.
Collapse
Affiliation(s)
- Peter Kalev
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Marc L Hyer
- Pharmacology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Stefan Gross
- Biochemistry and Biophysics, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Zenon Konteatis
- Chemistry, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Chi-Chao Chen
- Bioinformatics, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Mark Fletcher
- Bioinformatics, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Max Lein
- Drug Metabolism and Pharmacokinetics, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Elia Aguado-Fraile
- Clinical Biomarkers, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Victoria Frank
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Amelia Barnett
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Everton Mandley
- Pharmacology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Joshua Goldford
- Cell Metabolism, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Yue Chen
- Drug Metabolism and Pharmacokinetics, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Katie Sellers
- Cell Metabolism, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Sebastian Hayes
- Cell Metabolism, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Kate Lizotte
- Cell Metabolism, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Phong Quang
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Yesim Tuncay
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Michelle Clasquin
- Cell Metabolism, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Rachel Peters
- Toxicology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Jaclyn Weier
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Eric Simone
- Chemistry, Manufacturing and Control, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Joshua Murtie
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA; Pharmacology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Wei Liu
- Bioinformatics, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Raj Nagaraja
- Drug Metabolism and Pharmacokinetics, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Lenny Dang
- Biochemistry and Biophysics, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Zhihua Sui
- Chemistry, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Scott A Biller
- Chemistry, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Jeremy Travins
- Chemistry, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Kevin M Marks
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA
| | - Katya Marjon
- Biology, Agios Pharmaceuticals, Inc., Cambridge, MA 02139, USA.
| |
Collapse
|
5
|
Hartung A, Brennecke S, Lin K, Trabert D, Fehre K, Rist J, Schöffler MS, Jahnke T, Schmidt LPH, Kunitski M, Lein M, Dörner R, Eckart S. Electric Nondipole Effect in Strong-Field Ionization. Phys Rev Lett 2021; 126:053202. [PMID: 33605768 DOI: 10.1103/physrevlett.126.053202] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Accepted: 01/08/2021] [Indexed: 06/12/2023]
Abstract
Strong-field ionization of atoms by circularly polarized femtosecond laser pulses produces a donut-shaped electron momentum distribution. Within the dipole approximation this distribution is symmetric with respect to the polarization plane. The magnetic component of the light field is known to shift this distribution forward. Here, we show that this magnetic nondipole effect is not the only nondipole effect in strong-field ionization. We find that an electric nondipole effect arises that is due to the position dependence of the electric field and which can be understood in analogy to the Doppler effect. This electric nondipole effect manifests as an increase of the radius of the donut-shaped photoelectron momentum distribution for forward-directed momenta and as a decrease of this radius for backwards-directed electrons. We present experimental data showing this fingerprint of the electric nondipole effect and compare our findings with a classical model and quantum calculations.
Collapse
Affiliation(s)
- A Hartung
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - S Brennecke
- Institut für Theoretische Physik, Leibniz Universität Hannover, Appelstraße 2, 30167 Hannover, Germany
| | - K Lin
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
- State Key Laboratory of Precision Spectroscopy, East China Normal University, 200241, Shanghai, China
| | - D Trabert
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - K Fehre
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - J Rist
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - M S Schöffler
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - T Jahnke
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - L Ph H Schmidt
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - M Kunitski
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - M Lein
- Institut für Theoretische Physik, Leibniz Universität Hannover, Appelstraße 2, 30167 Hannover, Germany
| | - R Dörner
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| | - S Eckart
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
| |
Collapse
|
6
|
Hyer ML, Kalev P, Fletcher M, Chen CC, Aguado-Fraile E, Mandley E, Newhouse S, Lein M, Nagaraja R, Tuncay Y, Murtie J, Marks KM, Marjon K. Abstract 3090: The MAT2A inhibitor, AG-270, combines with both taxanes and gemcitabine to yield enhanced anti-tumor activity in patient-derived xenograft models. Cancer Res 2020. [DOI: 10.1158/1538-7445.am2020-3090] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
MAT2A (methionine adenosyltransferase 2 alpha) is a critical enzyme within the methionine salvage pathway responsible for generating the universal methyl group donor, S-adenosyl methionine (SAM). We have developed a first-in-class small molecule inhibitor of MAT2A, AG-270, currently in a phase 1 clinical study (ClinicalTrials.gov NCT03435250) for the treatment of patients with solid tumors or lymphomas with MTAP (methylthioadenosine phosphorylase) deletion. The MTAP gene is deleted in approximately 15% of all human cancers, including non-small cell lung cancer (NSCLC; ~15-25%), pancreatic (~25%) and esophageal (~30%) cancer, and glioblastoma (~50%). To prioritize candidate combination partners for AG-270, a cell-based in vitro screening approach was employed using MTAP-null cell lines, in which AG-270 was combined with standard-of-care (SOC) agents as well as agents targeting pathways with hypothesized mechanistic links to MAT2A. Some of the best performing enhancers from this screen included paclitaxel (and docetaxel, using orthogonal screens) and gemcitabine. To assess the robustness of these combination findings in clinically relevant in vivo models, a series of patient-derived xenograft (PDX) experiments was undertaken to evaluate tolerability and efficacy in mice. Results demonstrated that AG-270, when combined with taxanes (paclitaxel/docetaxel) or gemcitabine, was well tolerated using SOC plasma exposures less than or equal to those achieved in patients. Importantly, combining AG-270 with taxanes and gemcitabine yielded additive-to-synergistic anti-tumor activity, with the docetaxel combination yielding 50% complete tumor regressions (CRs) in 2-3 PDX models. To study the mechanism of action, MAT2A was inhibited in vitro within HCT-116 MTAP −/− and wild-type cells, and we observed RNA splicing changes (via detained introns) altering genes involved in cell cycle regulation and DNA damage response, with a more pronounced effect found in the MTAP −/− genetic setting. Moreover, detained introns involving these same two pathways were modulated in MTAP −/− NSCLC PDX models treated with AG-270. Taken together, these data suggest AG-270 complements the known mechanism of action of taxanes and gemcitabine, and leads to enhanced DNA damage and inhibition of cellular proliferation. This work has helped identify a therapeutic strategy of combining AG-270 with taxanes and gemcitabine, which is currently being explored in an ongoing phase 1 clinical trial (NCT03435250).
Page 1 of 1
Citation Format: Marc L. Hyer, Peter Kalev, Mark Fletcher, Chi-Chao Chen, Elia Aguado-Fraile, Everton Mandley, Sheila Newhouse, Max Lein, Raj Nagaraja, Yesim Tuncay, Josh Murtie, Kevin M. Marks, Katya Marjon. The MAT2A inhibitor, AG-270, combines with both taxanes and gemcitabine to yield enhanced anti-tumor activity in patient-derived xenograft models [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 3090.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Max Lein
- Agios Pharmaceuticals, Inc., Cambridge, MA
| | | | | | | | | | | |
Collapse
|
7
|
Abstract
Maxwell electromagnetism, describing the wave properties of light, was formulated 150 years ago. More than 60 years ago it was shown that interfaces between optical media (including dielectrics, metals, negative-index materials) can support surface electromagnetic waves, which now play crucial roles in plasmonics, metamaterials, and nano-photonics. Here we show that surface Maxwell waves at interfaces between homogeneous isotropic media described by real permittivities and permeabilities have a topological origin explained by the bulk-boundary correspondence. Importantly, the topological classification is determined by the helicity operator, which is generically non-Hermitian even in lossless optical media. The corresponding topological invariant, which determines the number of surface modes, is a \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\Bbb Z}_4$$\end{document}Z4 number (or a pair of \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\Bbb Z}_2$$\end{document}Z2 numbers) describing the winding of the complex helicity spectrum across the interface. Our theory provides a new twist and insights for several areas of wave physics: Maxwell electromagnetism, topological quantum states, non-Hermitian wave physics, and metamaterials. Electromagnetic surface waves, derived from Maxwell theory, underpin many optical effects and applications. Here, Bliokh et al. show that surface waves at interfaces between isotropic media have a topological origin described by the non-Hermitian helicity operator and bulk-boundary correspondence.
Collapse
Affiliation(s)
- Konstantin Y Bliokh
- Theoretical Quantum Physics Laboratory, RIKEN Cluster for Pioneering Research, Wako-shi, Saitama, 351-0198, Japan. .,Nonlinear Physics Centre, RSPE, The Australian National University, Canberra, ACT, 0200, Australia.
| | - Daniel Leykam
- Center for Theoretical Physics of Complex Systems, Institute for Basic Science (IBS), Daejeon, 34126, Republic of Korea
| | - Max Lein
- Advanced Institute of Materials Research, Tohoku University, Sendai, 980-8577, Japan
| | - Franco Nori
- Theoretical Quantum Physics Laboratory, RIKEN Cluster for Pioneering Research, Wako-shi, Saitama, 351-0198, Japan.,Physics Department, University of Michigan, Ann Arbor, MI, 48109-1040, USA
| |
Collapse
|
8
|
Eckart S, Fehre K, Eicke N, Hartung A, Rist J, Trabert D, Strenger N, Pier A, Schmidt LPH, Jahnke T, Schöffler MS, Lein M, Kunitski M, Dörner R. Direct Experimental Access to the Nonadiabatic Initial Momentum Offset upon Tunnel Ionization. Phys Rev Lett 2018; 121:163202. [PMID: 30387676 DOI: 10.1103/physrevlett.121.163202] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/03/2018] [Revised: 08/16/2018] [Indexed: 06/08/2023]
Abstract
We report on the nonadiabatic offset of the initial electron momentum distribution in the plane of polarization upon single ionization of argon by strong field tunneling and show how to experimentally control the degree of nonadiabaticity. Two-color counter- and corotating fields (390 and 780 nm) are compared to show that the nonadiabatic offset strongly depends on the temporal evolution of the laser electric field. We introduce a simple method for the direct access to the nonadiabatic offset using two-color counter- and corotating fields. Further, for a single-color circularly polarized field at 780 nm, we show that the radius of the experimentally observed donutlike distribution increases for increasing momentum in the light propagation direction. Our observed initial momentum offsets are well reproduced by the strong-field approximation. A mechanistic picture is introduced that links the measured nonadiabatic offset to the magnetic quantum number of virtually populated intermediate states.
Collapse
Affiliation(s)
- S Eckart
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - K Fehre
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - N Eicke
- Institut für Theoretische Physik, Leibniz Universität Hannover, Appelstr. 2, 30167 Hannover, Germany
| | - A Hartung
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - J Rist
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - D Trabert
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - N Strenger
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - A Pier
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - L Ph H Schmidt
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - T Jahnke
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - M S Schöffler
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - M Lein
- Institut für Theoretische Physik, Leibniz Universität Hannover, Appelstr. 2, 30167 Hannover, Germany
| | - M Kunitski
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| | - R Dörner
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Str. 1, 60438 Frankfurt, Germany
| |
Collapse
|
9
|
Abstract
A rare terminal cadmium hydride complex has been synthesised. Reduction to the cadmium(i) dimer complex was achieved upon treatment with carbodiimides.
Collapse
Affiliation(s)
- D. J. Webb
- School of Chemical and Physical Sciences
- Victoria University of Wellington
- PO Box 600
- Wellington
- New Zealand
| | - C. M. Fitchett
- Department of Chemistry
- University of Canterbury
- P.B. 4800
- Christchurch 8041
- New Zealand
| | - M. Lein
- School of Chemical and Physical Sciences
- Victoria University of Wellington
- PO Box 600
- Wellington
- New Zealand
| | - J. R. Fulton
- School of Chemical and Physical Sciences
- Victoria University of Wellington
- PO Box 600
- Wellington
- New Zealand
| |
Collapse
|
10
|
Abstract
Bismuth(iii) TEMPOxide complexes are active catalysts for oxidative coupling reactions to generate TEMPO silylethers.
Collapse
Affiliation(s)
- R. J. Schwamm
- School of Chemical and Physical Sciences
- Victoria University of Wellington
- Wellington 6012
- New Zealand
| | - M. Lein
- School of Chemical and Physical Sciences
- Victoria University of Wellington
- Wellington 6012
- New Zealand
| | - M. P. Coles
- School of Chemical and Physical Sciences
- Victoria University of Wellington
- Wellington 6012
- New Zealand
| | - C. M. Fitchett
- Department of Chemistry
- University of Canterbury
- Christchurch 8041
- New Zealand
| |
Collapse
|
11
|
Abstract
Exciton coupling is applied for the first time to successfully explain the excited-state structure of metalloazadipyrrins.
Collapse
Affiliation(s)
- T. M. McLean
- Institute of Fundamental Sciences
- Massey University
- Palmerston North, New Zealand
| | - S. G. Telfer
- Institute of Fundamental Sciences
- Massey University
- Palmerston North, New Zealand
| | | | - K. C. Gordon
- Department of Chemistry
- University of Otago
- Dunedin, New Zealand
| | - M. Lein
- School of Chemical and Physical Sciences
- Victoria University of Wellington
- Wellington, New Zealand
| | - M. R. Waterland
- Institute of Fundamental Sciences
- Massey University
- Palmerston North, New Zealand
| |
Collapse
|
12
|
Abstract
We have designed two novel devices which extend the applications for the droplet-interface bilayer (DIB) as a model membrane system. The add-chip allows successive reagent additions to one side of the lipid bilayer during an experiment while maintaining a simple setup with much lower volumes than in planar bilayer systems. The flow-chip is capable of multiple complete solution perfusions concurrently with electrophysiology measurements. Both devices preserve all of the key advantages that DIBs have relative to planar membranes, including low volume, leaflet asymmetry and the ability to separate the monolayers prior to further analysis of a droplet's contents. As a demonstration, we use these devices to monitor and quantitate molecular transport across DIBs.
Collapse
Affiliation(s)
- Max Lein
- Department of Chemistry, University of Massachusetts, 710 North Pleasant St, Amherst, MA 01003, USA
| | | | | |
Collapse
|
13
|
Huang J, Lein M, Gunderson C, Holden MA. Direct Quantitation of Peptide-Mediated Protein Transport across a Droplet–Interface Bilayer. J Am Chem Soc 2011; 133:15818-21. [DOI: 10.1021/ja2046342] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Jing Huang
- Department of Chemistry, University of Massachusetts, 710 North Pleasant Street, Amherst, Massachusetts 01003, United States
| | - Max Lein
- Department of Chemistry, University of Massachusetts, 710 North Pleasant Street, Amherst, Massachusetts 01003, United States
| | - Christopher Gunderson
- Department of Chemistry, University of Massachusetts, 710 North Pleasant Street, Amherst, Massachusetts 01003, United States
| | - Matthew A. Holden
- Department of Chemistry, University of Massachusetts, 710 North Pleasant Street, Amherst, Massachusetts 01003, United States
| |
Collapse
|
14
|
Nitzsche B, Gloesenkamp C, Schrader M, Ocker M, Preissner R, Lein M, Zakrzewicz A, Hoffmann B, Höpfner M. Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours. Br J Cancer 2010; 103:18-28. [PMID: 20551952 PMCID: PMC2905278 DOI: 10.1038/sj.bjc.6605725] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Testicular germ cell tumour (TGCT) is the most common cause of death from solid tumours in young men and especially for platinum-refractory patients novel treatment approaches are urgently needed. Using an in silico screening approach for the detection of novel cancer drugs with inhibitory effects on the tyrosine kinase activity of growth factors (e.g., VEGFR, PDGFR), we identified two compounds (HP-2 and HP-14) with antiangiogenic and antiproliferative potency, which were evaluated in endothelial cell models and TGCT cells. RESULTS HP-2 and HP-14 effectively inhibited the growth of VEGFR-2-expressing TGCT cell lines (Tera-1, Tera-2 and 2102EP) and endothelial cell models, while they failed to supress the growth of VEGFR-2-lacking tumour cells. cDNA-microarrays revealed an inhibition of the expression of several growth factor receptors and related signal transduction molecules. Vascular endothelial growth factor (VEGF)-induced cell migration was also potently inhibited. Cell cycle-regulating proteins such as p21 and p27 were upregulated, leading to an S-phase arrest. Additional in vivo evaluations confirmed the antiangiogenic potency and good tolerability of the novel substances. CONCLUSION Our data show that the identified novel compounds inhibit the growth of TGCT cells and decrease angiogenic microvessel formation. The mode of action involves cell cycle arresting effects and changes in the expression pattern of several angiogenic genes. The novel compounds may qualify as new candidates for targeted treatment of TGCT and merit further evaluation.
Collapse
Affiliation(s)
- B Nitzsche
- Department of Physiology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Arnimallee 22, Berlin 14195, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
15
|
|
16
|
Busch J, Röllig C, Weissbach L, Kempkensteffen C, Hinz S, Jahnke C, Schostak M, Lein M, Weikert S, Stephan C, Deger S, Ollenschläger G, Miller K, Schrader M. [What is most important is what comes across : Urological guidelines from the target group's point of view]. Urologe A 2009; 49:75-80. [PMID: 19830402 DOI: 10.1007/s00120-009-2134-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND Guidelines are developed to improve the quality of patient care. The effect of German urologic guidelines has not been evaluated so far. Therefore, we aimed to systematically investigate the acceptance, use, and quality of the published guidelines from a user's perspective. METHODS A link to an online questionnaire concerning use and barriers to the application of guidelines was distributed via e-mail by the German Society of Urology (DGU). German urologists' opinions on differences in national guideline quality were evaluated regarding prostate cancer (PCA), bladder cancer, germ cell tumors (GCT), renal cell carcinomas, and erectile dysfunction. RESULTS Four hundred sixty-seven German urologists participated. More than 90% of the participants considered guidelines to be helpful. The Internet as the main tool for guideline distribution was favored by 28.4%, followed by publication in Urologe A. The main barrier to guideline usage was attributed to the lack of up-to date clinical data. Guidelines for GCT scored best in all quality categories and reached the highest level of use (65.8%), and 40.5% of participating urologists considered the additional establishment of comprehensive care centers for GCT as more effective for quality improvement than guideline development alone. For the other urologic tumors, especially PCA, guideline development was favored as a tool for quality improvement. CONCLUSION More than 90% of participating urologists accept clinical guidelines as useful instruments in clinical practice and for therapeutic decisions. Our results should be integrated into guideline dissemination and implementation strategies in order to achieve a higher degree of treatment conformation to guidelines.
Collapse
Affiliation(s)
- J Busch
- Klinik für Urologie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Stephan C, Cammann H, Rittenhouse H, Lein M, Jentzmik F, Schrader M, Deger S, Miller K, Jung K. [New biomarkers and application of multivariate models for detection of prostate cancer]. Aktuelle Urol 2009; 40:221-30. [PMID: 19634072 DOI: 10.1055/s-0029-1224535] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
The specificity of PSA has been enhanced by using molecular forms of PSA and free PSA (fPSA) such as percent free PSA (%fPSA), proPSA, intact PSA or BPHA and / or new serum markers. Most of these promising new serum markers like EPCA2 or ANXA3 still lack confirmation of the outstanding initial results or show only marginally enhanced specificity at high sensitivity levels. PCA3, TMPRSS2-ERG, and other analytes in urine collected after digital rectal examination with application of mild digital pressure have the potential to preferentially detect aggressive PCa and to decrease the number of unnecessary repeat biopsies. The combination of these new urinary markers with new and established serum markers seems to be most promising to further increase specificity of tPSA. Multivariate models, e. g., artificial neural networks (ANN) or logistic regression (LR) based nomograms have recently been performed by incorporating these new markers in several studies. There is generally an advantage to include the new markers and clinical data as additional parameters to PSA and %fPSA within ANN and LR models. Results of these studies and also unexpected pitfalls are discussed in this review.
Collapse
|
18
|
Abstract
Laparoscopic live donor nephrectomy (LDN) has removed disincentives of potential donors and may bear the potential to increase kidney donation. Multiple modifications have been made to abbreviate the learning curve while at the same time guarantee the highest possible level of medical quality for donor and recipient. We reviewed the literature for the evolution of the different LDN techniques and their impact on donor, graft and operating surgeon, including the subtleties of different surgical accesses, vessel handling and organ extraction. We performed a literature search (PubMed, DIMDI, medline) to evaluate the development of the LDN techniques from 1995 to 2003. Today more than 200 centres worldwide perform LDN. Hand-assistance has led to a spread of LDN. Studies comparing open and hand-assisted LDN show a reduction of operating and warm ischaemia times for the hand-assisted LDN. Different surgical access sites (trans- or retroperitoneal), different vessel dissection approaches, donor organ delivery techniques, delivery sites and variations of hand-assistance techniques reflect the evolution of LDN. Proper techniques and their combination for the consecutive surgical steps minimize both warm ischaemia time and operating time while offering the donor a safe minimally invasive laparoscopic procedure. LDN has breathed new life into the moribund field of living kidney donation. Within a few years LDN could become the standard approach in living kidney donation. Surgeons working in this field must be trained thoroughly and well acquainted with the subtleties of the different LDN techniques and their respective advantages and disadvantages.
Collapse
Affiliation(s)
- S Deger
- Department of Urology, Charité Campus Mitte, Charité University Medicine Berlin, Germany.
| | | | | | | | | | | | | |
Collapse
|
19
|
Kristiansen G, Fritzsche FR, Wassermann K, Jäger C, Tölls A, Lein M, Stephan C, Jung K, Pilarsky C, Dietel M, Moch H. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer 2009; 99:939-48. [PMID: 18781151 PMCID: PMC2538754 DOI: 10.1038/sj.bjc.6604614] [Citation(s) in RCA: 100] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
GOLPH2 is coding the 73-kDa type II Golgi membrane antigen GOLPH2/GP73. Upregulation of GOLPH2 mRNA has been recently reported in expression array analyses of prostate cancer. As GOLPH2 protein expression in prostate tissues is currently unknown, this study aimed at a comprehensive analysis of GOLPH2 protein in benign and malignant prostate lesions. Immunohistochemically detected GOLPH2 protein expression was compared with the basal cell marker p63 and the prostate cancer marker alpha-methylacyl-CoA racemase (AMACR) in 614 radical prostatectomy specimens. GOLPH2 exhibited a perinuclear Golgi-type staining pattern and was preferentially seen in prostatic gland epithelia. Using a semiquantitative staining intensity score, GOLPH2 expression was significantly higher in prostate cancer glands compared with normal glands (P<0.001). GOLPH2 protein was upregulated in 567 of 614 tumours (92.3%) and AMACR in 583 of 614 tumours (95%) (correlation coefficient 0.113, P = 0.005). Importantly, GOLPH2 immunohistochemistry exhibited a lower level of intratumoral heterogeneity (25 vs 45%). Further, GOLPH2 upregulation was detected in 26 of 31 (84%) AMACR-negative prostate cancer cases. These data clearly suggest GOLPH2 as an additional ancillary positive marker for tissue-based diagnosis of prostate cancer.
Collapse
Affiliation(s)
- G Kristiansen
- Department of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Deger S, Lein M, Miller K, Wille A. [New developments in minimally invasive urology: NOTES (Natural Orifice Transluminal Endoscopic Surgery) and LESS (Laparo-Endoscopic Single-Site Surgery) in urology]. Aktuelle Urol 2009; 40:23-6. [PMID: 19177317 DOI: 10.1055/s-0028-1098785] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Laparoscopic surgery in urology has undergone a rapid development in the last decade. In general, many studies have underlined the benefits of laparoscopy in urology. The latest innovations in the field of minimally invasive urology are aimed at a further reduction of the morbidity associated with minimally invasive surgery. Two novel innovations are currently being developed, natural orifice transluminal endoscopic surgery (NOTES), whereby intraperitoneal access is gained through natural orifices and laparo-endoscopic single-site surgery (LESS), wherein one surgical access is used both for introducing instruments and for retrieving the specimen. Many case reports and small patient series have been published rapidly in the past two years. However, comparative randomised studies to conventional laparoscopy or open surgery do not yet exist. LESS and NOTES are two new innovative approaches, whereby feasibility studies not only for simple nephrectomy but also for complex procedures like partial nephrectomy, radical prostatectomy, ureterocystoneostomy have been published. In the next few years, comparative studies between these techniques and conventional laparoscopy can be expected.
Collapse
|
21
|
Ebbing J, Christoph F, Kempkensteffen C, Weikert S, Schostak M, Hinz S, Lein M, Miller K, Schrader M. [Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options]. Aktuelle Urol 2008; 39:429-35. [PMID: 18979397 DOI: 10.1055/s-2008-1038284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
This article offers a review about the current facts of chemotherapy in testicular cancer. Besides a short presentation of the guideline-standard therapy the authors deal with the question as to why testicular cancer shows an extraordinarily high chemosensibility compared to other tumours. Furthermore, the current data on alternative chemotherapies as well as of molecular, molecular-genetic and pharmacogenetic therapeutic concepts are explored. Data were obtained from researches in Medline of the Pubmed database.
Collapse
|
22
|
Miller K, Lein M, Schostak M, Schrader M. [Adjuvant and neoadjuvant drug therapy for prostate cancer]. Urologe A 2008; 47:1460-4. [PMID: 18813902 DOI: 10.1007/s00120-008-1728-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Neoadjuvant and adjuvant therapeutic strategies are widely employed for a variety of cancer entities. The basic aim and the potential benefit for the patient are to eradicate micrometastases, with the downside being side effects and overtreatment. Neoadjuvant and adjuvant hormone therapy for prostate cancer have been investigated in a number of clinical studies. Based on these studies, the following recommendations can be given: there is currently no indication for neoadjuvant therapy prior to radical prostatectomy. Adjuvant therapy using LHRH analogs for patients with lymph node-positive tumors following radical prostatectomy can be considered but should be weighed against early"biochemical progression triggered" treatment. For locally advanced tumors the same is true (bicalutamide): adjuvant treatment has shown an advantage in clinically progression-free survival; however, no systematic comparison is available with early"biochemical progression triggered" treatment. Before radiotherapy 2 months of neoadjuvant LHRH analog treatment has shown a survival advantage in patients with locally advanced tumors and a low risk of systemic spread (Gleason <7). For high-risk patients, long-term (2-3 years) adjuvant LHRH analog treatment is indicated.
Collapse
Affiliation(s)
- K Miller
- Klinik und Hochschulambulanz für Urologie, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12200, Berlin, Deutschland.
| | | | | | | |
Collapse
|
23
|
Baker S, Robinson JS, Lein M, Chirilă CC, Torres R, Bandulet HC, Comtois D, Kieffer JC, Villeneuve DM, Tisch JWG, Marangos JP. Dynamic two-center interference in high-order harmonic generation from molecules with attosecond nuclear motion. Phys Rev Lett 2008; 101:053901. [PMID: 18764392 DOI: 10.1103/physrevlett.101.053901] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2007] [Revised: 11/22/2007] [Indexed: 05/26/2023]
Abstract
We report a new dynamic two-center interference effect in high-harmonic generation from H2, in which the attosecond nuclear motion of H2+ initiated at ionization causes interference to be observed at lower harmonic orders than would be the case for static nuclei. To enable this measurement we utilize a recently developed technique for probing the attosecond nuclear dynamics of small molecules. The experimental results are reproduced by a theoretical analysis based upon the strong-field approximation which incorporates the temporally dependent two-center interference term.
Collapse
Affiliation(s)
- S Baker
- Department of Physics, Imperial College London, London, United Kingdom.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Gralla O, Buchser M, Haas F, Anders E, Kramer J, Lein M, Knoll N, Roigas J. „Fast-track“ bei laparoskopisch radikaler Prostatektomie. Urologe A 2008; 47:712-7. [DOI: 10.1007/s00120-008-1688-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
25
|
Lein M, Stephan C, Jung K, Koenig F, Schnorr D, Loening S. Das Verhältnis freies PSA/Gesamt-PSA - eine Kenngröße zur Differenzierung zwischen Patienten mit Prostatakarzinom und benigner Prostatahyperplasie: Welcher Diskriminationspunkt sollte gewählt werden? Aktuelle Urol 2008. [DOI: 10.1055/s-2008-1054297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
26
|
Fahlenkamp D, Beer M, Schönberger B, Lein M, Türk I, Loening S. Laparoskopische Adrenalektomie. Aktuelle Urol 2008. [DOI: 10.1055/s-2008-1055628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
27
|
Abstract
Of visitors to the Men's Health Awareness Days (Männergesundheitstage) in different German cities, 2,200 were asked to answer a standardised questionnaire about the quality of the information presented. Fifty-one per cent of the visitors answered; of those 80% gave mainly positive feedback, especially for a walk-through prostate model and for the presentations and discussions. Visitors represented only partial groups concerning age (64 years on average), existing prostate disease (51%), and participation in examinations for early detection (cancer screening). Therefore, many of the visitors did not represent the target group (healthy and under 60 years old). Qualified urologists could make better use of consultations by informing patients about local or general information events such as these. As men are burdened with multiple health risks, future Health Days should make use of interdisciplinary schemes.
Collapse
Affiliation(s)
- L Weissbach
- Privatärztliche Urologische Gemeinschaftspraxis, EuromedClinic, Europa-Allee 1, 90763, Fürth.
| | | | | | | |
Collapse
|
28
|
Røe C, Dalen H, Lein M, Bautz-Holter E. Comprehensive rehabilitation at Beitostølen Healthsports Centre: Influence on mental and physical functioning. J Rehabil Med 2008; 40:410-7. [DOI: 10.2340/16501977-0179] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
29
|
Lein M, Ramankulov A, Stephan C, Kramer J, Loening SA, Jung K. Neue Serummarker zur Diagnostik von Knochenmetastasen beim Prostatakarzinom. Urologe A 2007; 46:1087-8. [PMID: 17628774 DOI: 10.1007/s00120-007-1437-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- M Lein
- Klinik für Urologie, Charité--Universitätsmedizin Berlin, Charité Campus Mitte, Charitéplatz 1, 10117 Berlin.
| | | | | | | | | | | |
Collapse
|
30
|
Stephan C, Jung K, Cammann H, Kramer J, Kristiansen G, Loening SA, Lein M. Neue Serummarker des Prostatakarzinoms und ihr Einsatz in artifiziellen neuronalen Netzwerken (ANN). Urologe A 2007; 46:1084-6. [PMID: 17641867 DOI: 10.1007/s00120-007-1435-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- C Stephan
- Klinik für Urologie, Charité--Universitätsmedizin Berlin, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin.
| | | | | | | | | | | | | |
Collapse
|
31
|
Wirth M, Schmidt K, Miller K, Eickenberg H, Lein M, Haus U, Stöckle M, Graefen M, Stenzl A, Effert P. 304 TREATMENT WITH ZOLENDRONIC ACID IS BENEFICIAL BEFORE ONSET OF SKELETAL MORBIDITY IN PATIENTS WITH BONE METASTASES FROM PROSTATE CANCER. ACTA ACUST UNITED AC 2007. [DOI: 10.1016/s1569-9056(07)60303-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
32
|
Gralla O, Haas F, Knoll N, Hadzidiakos D, Tullmann M, Romer A, Deger S, Ebeling V, Lein M, Wille A, Rehberg B, Loening SA, Roigas J. Fast-track surgery in laparoscopic radical prostatectomy: basic principles. World J Urol 2006; 25:185-91. [PMID: 17171563 DOI: 10.1007/s00345-006-0139-2] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2006] [Accepted: 11/01/2006] [Indexed: 01/15/2023] Open
Abstract
Fast-track surgery describes innovative treatment concepts ensuring a faster convalescence phase. The aim of this study was to allow hospital discharge 3 days after surgery without additional complications in patients receiving LRPE for localized prostate cancer. Twenty-five patients each were randomized in the study groups to verify if a fast-track regimen could be transferred into clinical routine. The perioperative data, early complications, hospital stay as well as readmission rate were analyzed. The mean postoperative stay was 3.6 days in the fast-track group versus 6.7 days in the conventional group. The overall complications were significantly less in the fast-track procedure. The readmission rate was low and not significant. Patients receiving an LRPE benefit from a suitable fast-track concept. The postoperative hospital stay could be shortened nearly by half with a significantly decreased overall complication rate. Thus, fast-track concepts might contribute to saving resources in the long term. However, more evidence based on larger prospective trials is needed to achieve optimal quality of life for patients perioperatively.
Collapse
Affiliation(s)
- O Gralla
- Department of Urology, Campus Mitte, Charité-Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Fischer R, Lein M, Keitel CH. Enhanced recollisions for antisymmetric molecular orbitals in intense laser fields. Phys Rev Lett 2006; 97:143901. [PMID: 17155251 DOI: 10.1103/physrevlett.97.143901] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/23/2006] [Indexed: 05/12/2023]
Abstract
The peculiarities of antisymmetric molecular orbitals are investigated in very intense linearly polarized laser pulses. For this purpose, the ionization-recollision quantum dynamics is evaluated theoretically beyond the dipole approximation. As opposed to the usual situation, the laser magnetic field component is found to strongly enhance recollision probabilities for particularly oriented antisymmetric molecular orbitals. Harmonic generation and related processes are thus allowed at high laser intensities without the common limitations by the laser magnetic field.
Collapse
Affiliation(s)
- R Fischer
- Max-Planck-Institut für Kernphysik, Saupfercheckweg 1, 69117 Heidelberg, Germany.
| | | | | |
Collapse
|
34
|
Beutner S, May M, Hoschke B, Helke C, Lein M, Roigas J, Johannsen M. Treatment of varicocele with reference to age: a retrospective comparison of three minimally invasive procedures. Surg Endosc 2006; 21:61-5. [PMID: 17024538 DOI: 10.1007/s00464-005-0684-6] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2005] [Accepted: 04/02/2006] [Indexed: 10/24/2022]
Abstract
BACKGROUND This study investigated whether the therapeutic efficacy and morbidity of three minimally invasive techniques for varicocele correction--laparoscopic varicocelectomy (LV), antegrade sclerotherapy (AS), and retrograde embolization (RE)--differed between children and adults. METHODS During a 10-year period, 356 procedures for varicocele correction, including 122 cases of LV, 108 cases of AS, and 126 cases of RE, were performed for 314 patients at our institution. Of these patients, 223 were 19 years of age or younger (group 1), and 133 were older than 19 years (group 2). Diagnosis and postoperative results were established clinically and with the use of Doppler ultrasonography. The failure rates and complications for each procedure were retrospectively evaluated and compared between the two age groups. RESULTS The median follow-up period was 69 months (range, 6-122 months). For 25 patients (19.8%), RE was not feasible for technical reasons. In both groups, LV had a lower failure rate than AS or RE, but the difference between LV and AS was not significant in group 1 (7.7(% vs 11.9%; p > 0.5). Also in group 1, AS was associated with fewer complications than LV 1 (4.5% vs 15.4%; p < 0.05). In group 2, LV was significantly more effective in correcting varicoceles than the other two techniques (p < 0.01). In this group, the complication rates for all three procedures did not differ significantly (p > 0.05). CONCLUSIONS In our experience, LV was more effective than AS or RE in correcting varicoceles. For children and adolescents, AS may be more indicated because of the slightly lower complication rate and similar recurrence rates, as compared with LV, for this age group. The higher incidence of postoperative hydrocele formation after LV warrants more refined techniques such as the lymphatic-sparing approach.
Collapse
Affiliation(s)
- S Beutner
- Department of Urology, Carl-Thiem Hospital, Cottbus, Germany
| | | | | | | | | | | | | |
Collapse
|
35
|
Abstract
OBJECTIVE The literature regarding the constitutional type of children and adolescents with varicocele is inconsistent. The aim of this investigation was to examine a possible influence of weight, height and body mass index (BMI) on the formation of varicoceles during childhood and adolescence. MATERIAL AND METHODS In a retrospective data analysis, 193 Caucasian children and adolescents aged 9-19 years (mean age 14.7 years) with left-sided varicocele grade 2-3 were studied. The weight, height and BMI of the subjects were compared with the age-correlated normal values currently accepted in Germany. Additionally, the familial disposition for varicocele and the occurrence of relevant concurrent diseases were considered. RESULTS In the group of patients examined, the mean percentiles of weight (57th) and height (58th) were significantly above and the mean BMI percentile (42th) was significantly below the age-correlated 50th percentile for the normal population (p=0.019, 0.005 and 0.002). In our case material, 12.2% of all brothers of the patients had varicoceles. CONCLUSIONS The results of this investigation suggest a correlation between physical appearance and the formation of a varicocele during childhood or adolescence. We were able to demonstrate that patients with varicocele were heavier and taller than an age-correlated normal population, but had a distinctly lower BMI. Further studies are needed to verify whether this rather athletic habitus, together with the postulated difference in muscle:fat ratio, represents an important etiologic factor for varicocele formation.
Collapse
Affiliation(s)
- M May
- Department of Urology, Carl-Thiem Hospital Cottbus, Cottbus, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Baker S, Robinson JS, Haworth CA, Teng H, Smith RA, Chirila CC, Lein M, Tisch JWG, Marangos JP. Probing Proton Dynamics in Molecules on an Attosecond Time Scale. Science 2006; 312:424-7. [PMID: 16513942 DOI: 10.1126/science.1123904] [Citation(s) in RCA: 276] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
We demonstrate a technique that uses high-order harmonic generation in molecules to probe nuclear dynamics and structural rearrangement on a subfemtosecond time scale. The chirped nature of the electron wavepacket produced by laser ionization in a strong field gives rise to a similar chirp in the photons emitted upon electron-ion recombination. Use of this chirp in the emitted light allows information about nuclear dynamics to be gained with 100-attosecond temporal resolution, from excitation by an 8-femtosecond pulse, in a single laser shot. Measurements on molecular hydrogen and deuterium agreed well with calculations of ultrafast nuclear dynamics in the H2+ molecule, confirming the validity of the method. We then measured harmonic spectra from CH4 and CD4 to demonstrate a few-femtosecond time scale for the onset of proton rearrangement in methane upon ionization.
Collapse
Affiliation(s)
- S Baker
- Blackett Laboratory, Imperial College London, Prince Consort Road, South Kensington, London SW7 2BZ, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Braun JP, Walter M, Lein M, Roigas J, Schwilk B, Moshirzadeh M, Eveslage K, Rehberg-Klug B, Hansen D, Spies C. Klinischer Behandlungspfad „laparoskopische Prostatektomie“. Anaesthesist 2005; 54:1186-96. [PMID: 16075255 DOI: 10.1007/s00101-005-0905-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
METHODS In this study we investigated the anesthesiological module of a clinical pathway. We chose the pathway of "laparoscopic prostatectomy" as an example for time-consuming minimally invasive surgery and 40 patients were randomly assigned to 2 groups receiving either total intravenous anesthesia (TIVA) using propofol/ remifentanil or balanced minimal flow anesthesia using desflurane/ remifentanil. During this module the indicators of quality such as vigilance, pain, postoperative nausea and vomiting (PONV) and mobilization were measured. Costs were evaluated and analyzed by a bottom-up procedure. RESULTS There were no anesthesia-related deviations from clinical pathways and both forms of anesthesia management were equally well tolerated by the patients. No significant difference was observed regarding hemodynamic measurements or PONV. The patients in the desflurane/ remifentanil group recovered more rapidly (p=0.037) and had more pain. The amount of analgesic agents given immediately following anesthesia was significantly higher than in the TIVA group (p=0.017). The median anesthesia costs per minute for laparoscopic prostatectomy in the propofol group were 2.79 EUR (minimum cost 2.41 EUR, maximum cost 3.21 EUR) and in the desflurane group 2.68 EUR (minimum cost 2.45 EUR, maximum cost 3.39 EUR). The total anesthesia costs for both groups were within the proceeds matrix range for diagnosis-related groups (DRG). However, the cost analysis for medication was slightly higher than the proceeds matrix range for DRGs. CONCLUSION Both forms of anesthesia can be implemented for time-consuming surgical procedures and allow a cost-effective anesthesia management. Anesthesiological procedures must go hand-in-hand with the type of anesthesia selected. The prophylactic use of analgetics for desflurane/ remifentanil anesthesia should be given earlier and in higher doses than in propofol/ remifentanil anesthesia. The prophylactic use of antiemetics following laparoscopic procedures of long duration is indicated. Optimizing anesthesiological procedures could lead to a continuous improvement in the quality of therapeutic pathways.
Collapse
Affiliation(s)
- J-P Braun
- Klinik für Anästhesiologie und operative Intensivmedizin, Charité Universitätsmedizin, Campus Mitte, Schumannstrasse 20-21, 10117 Berlin.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Stephan C, Lein M, Schnorr D, Loening SA, Jung K. Repeating the measurement of prostate-specific antigen in symptomatic men can avoid unnecessary prostatic biopsy. BJU Int 2004; 93:1360-1. [PMID: 15180645 DOI: 10.1111/j.1464-410x.2004.4886e.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
39
|
Stephan C, Vogel B, Cammann H, Lein M, Klevecka V, Sinha P, Kristiansen G, Schnorr D, Jung K, Loening SA. Nutzung von artifiziellen neuronalen Netzwerken zur Risikoabsch�tzung eines Prostatakarzinoms. Urologe A 2003; 42:1221-9. [PMID: 14504755 DOI: 10.1007/s00120-003-0322-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
In this prospective study covering 5.5 years we evaluated the diagnostic power of an artificial neural network (ANN) based on PSA, %fPSA, and clinical data in the PSA range 2-20 microg/l as prostate biopsy indicator. A total of 944 patients with prostate cancer or benign hyperplasia (BPH) were analyzed. The calculation of the individual patient's risk before prostate biopsy was performed at the 90% and 95% specificity and sensitivity levels within the PSA ranges 2-4, 4.1-10, and 10.1-20 microg/l. For the low PSA range 2-4 microg/l, we recommend a first time biopsy at an ANN specificity level of 95%. For PSA range 4.1-10 microg/l, we recommend a first time biopsy at an ANN sensitivity level of 95%. A rebiopsy at the PSA range 10.1-20 micro g/l should be performed based on a 95% sensitivity level. The use of an ANN at PSA 2-20 microg/l enhances the specificity and sensitivity of %fPSA by 9-39%. The application of an ANN based on %fPSA and clinical data improves the diagnostic performance compared to %fPSA only.
Collapse
Affiliation(s)
- C Stephan
- Klinik und Poliklinik für Urologie, Universitätsklinikum Charité, Humboldt-Universität, Berlin.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Jung K, Lein M, Hösslin KV, Grosse A, Roth S, Possinger K, Lüftner D. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adults. Int J Biol Markers 2002; 17:177-81. [PMID: 12408468 DOI: 10.1177/172460080201700306] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
AIMS Osteoprotegerin and the receptor activator of the nuclear factor-kappaB ligand (RANKL) are decisive factors for maintaining the balance between bone formation and bone resorption. As new, sensitive ELISAs have been developed recently, reference serum ranges should be established to use these analytes for possible diagnostic purposes. METHODS Measurements were performed in serum samples of 142 healthy adults (82 women, 60 men) between 20 and 70 years of age (mean age: 46 years) using ELISA kits from Immundiagnostik, Bensheim, Germany. RESULTS Serum concentrations of osteoprotegerin were age and gender independent and showed a Gaussian distribution, while RANKL concentrations were also age independent but differed between males and females, with a non-Gaussian distribution. For osteoprotegerin a gender-independent upper 97.5 percentile limit of 3.6 pmol/L was calculated while the corresponding limits for RANKL and the ratio of RANKL to osteoprotegerin amounted to 3.29 pmol/L and 2.78 in women and 1.66 pmol/L and 2.18 in men, respectively. CONCLUSIONS Both osteoprotegerin and RANKL were quantifiable in serum of healthy adults, which means that these compounds can be used as potential diagnostic tools.
Collapse
Affiliation(s)
- K Jung
- Department of Urology, University Hospital Charité, Humboldt University Berlin, Germany
| | | | | | | | | | | | | |
Collapse
|
41
|
Mangoldt D, Sinn B, Lein M, Krell HW, Schnorr D, Loening SA, Jung K. The novel synthetic inhibitor of matrix metalloproteinases Ro 28-2653 induces apoptosis in Dunning tumor cells. Apoptosis 2002; 7:217-20. [PMID: 11997665 DOI: 10.1023/a:1015383231080] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The effect of synthetic inhibitors of matrix metalloproteinases (MMP) has been shown against a variety of tumors in preclinical models. Ro 28-2653, a novel synthetic MMP inhibitor, is able to reduce tumor growth in orthotopic prostatic cancer in rats (R3327 Dunning tumor). However, at present this inhibitory mechanism in tumor inhibition in vivo can only be partly explained by the inhibition of the catalytic activity of MMPs overexpressed in cancereous tissue. Using the flow cytometric method, we have investigated the effect of various concentrations of Ro 28-2653 on the Dunning tumor cells with regard to the staining of F-actin and DNA as markers of apoptosis. In combination with fluorescence microscopy we detected the loss of F-actin and the degradation of internucleosomal DNA. This effect of Ro 28-2653 on apoptosis was dose- and time-dependent increasing with concentration between 10 and 100 microg/ml as well as with time of treatment between 24 and 48 h.
Collapse
Affiliation(s)
- D Mangoldt
- Department of Urology, University Hospital Charité, Humboldt University, Berlin, Germany
| | | | | | | | | | | | | |
Collapse
|
42
|
Lein M, Hay N, Velotta R, Marangos JP, Knight PL. Role of the intramolecular phase in high-harmonic generation. Phys Rev Lett 2002; 88:183903. [PMID: 12005685 DOI: 10.1103/physrevlett.88.183903] [Citation(s) in RCA: 62] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/06/2001] [Indexed: 05/23/2023]
Abstract
We study numerically the generation of high-order harmonics by two-center molecules for arbitrary angles between the molecular axis and the laser polarization axis. For fixed angle, the harmonic spectrum exhibits a minimum at a frequency which is independent of the laser parameters. The amplitude of each harmonic is strongly angle dependent, and a pronounced minimum is found at the same angle where a sudden jump in the harmonic phase occurs. By calculating the spatial dependence of the harmonic amplitudes and phases, we are able to explain these effects in terms of interfering contributions from various regions within the molecule.
Collapse
Affiliation(s)
- M Lein
- Blackett Laboratory, Imperial College of Science, Technology and Medicine, London SW7 2BW, United Kingdom
| | | | | | | | | |
Collapse
|
43
|
Stephan C, Jung K, Schnorr D, Lein M, Sinha P, Loening S. RE: A PROSPECTIVE STUDY TO EVALUATE THE ROLE OF COMPLEXED PROSTATE SPECIFIC ANTIGEN AND FREE/TOTAL PROSTATE SPECIFIC ANTIGEN RATIO FOR THE DIAGNOSIS OF PROSTATE CANCER. J Urol 2002. [DOI: 10.1016/s0022-5347(05)65437-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
44
|
Stephan C, Jung K, Schnorr D, Lein M, Sinha P, Loening SA. Re: a prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. I.D.C. Mitchell, B.L. Croal, A. Dickie, N.P. Cohen and I. Ross. J Urol, 165: 1549-1553, 2001. J Urol 2002; 167:259-60. [PMID: 11743329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
|
45
|
Jung K, Lein M, Laube C, Lichtinghagen R. Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta 2001; 314:241-4. [PMID: 11718702 DOI: 10.1016/s0009-8981(01)00679-9] [Citation(s) in RCA: 83] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
BACKGROUND Matrix metalloproteinases (MMP) in blood are promising new diagnostic tools. It was shown that the blood sampling process resulted in different blood concentrations of MMPs. To clarify whether the sampling process also influences the diagnostic validity of MMPs, MMP-9 measurements were performed in plasma and serum samples of patients with prostate carcinoma and renal cell cancer. METHODS MMP-9 ELISAs were performed in samples of heparin plasma and serum collected in blood tubes with and without clot accelerator. Measurements were undertaken in 78 healthy persons, 33 patients with prostate carcinoma and 33 patients with renal cell carcinoma. RESULTS MMP-9 showed higher concentrations in serum samples than in heparin plasma and was about threefold higher in serum samples collected in tubes with clot activator than in native serum samples. Both patient groups had lower MMP-9 concentrations in serum, whereas in plasma, patients with renal cell carcinoma had higher, but patients with prostate cancer unchanged MMP-9 concentrations. 13 of 33 patients with renal cell carcinoma had increased MMP-9 plasma values but no patient had increased serum concentrations. CONCLUSIONS To optimise the diagnostic validity of the MMP-9 in blood, measurements should be performed in heparin plasma but not in serum.
Collapse
Affiliation(s)
- K Jung
- Department of Urology, University Hospital Charité, Humboldt University Berlin, Schumannstrasse 20/21, D-10098 Berlin, Germany.
| | | | | | | |
Collapse
|
46
|
Jung K, Lein M, von Hösslin K, Brux B, Schnorr D, Loening SA, Sinha P. Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer. Clin Chem 2001; 47:2061-3. [PMID: 11673385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Affiliation(s)
- K Jung
- Department of Urology, University Hospital Charité, Humboldt University Berlin, D-10098 Berlin, Germany
| | | | | | | | | | | | | |
Collapse
|
47
|
Lein M, Frunzke J, Timoshkin A, Frenking G. Iron bispentazole Fe(eta5-N5)2, a theoretically predicted high-energy compound: structure, bonding analysis, metal-ligand bond strength and a comparison with the isoelectronic ferrocene. Chemistry 2001; 7:4155-63. [PMID: 11686594 DOI: 10.1002/1521-3765(20011001)7:19<4155::aid-chem4155>3.0.co;2-m] [Citation(s) in RCA: 148] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Quantum-chemical calculations with gradient-corrected (B3LYP) density functional theory have been carried out for iron bispentazole and ferrocene. The calculations predict that Fe(eta5-N5)2 is a strongly bonded complex which has D5d symmetry. The theoretically predicted total bond energy that yields Fe in the 5D ground state and two pentazole ligands is Do = 109.0 kcal mol(-1), which is only 29 kcal mol(-1) less than the calculated bond energy of ferrocene (Do = 138.0 kcal mol(-1); experimental: 158 +/- 2 kcal mol(-1)). The compound Fe(eta5-N5)2 is 260.5 kcal mol(-1) higher in energy than the experimentally known isomer Fe(N2)5, but the bond energy of the latter (Do = 33.7 kcal mol(-1)) is much less. The energy decomposition analyses of Fe(eta5-N5)2 and ferrocene show that the two compounds have similar bonding situations. The metal-ligand bonds are roughly half ionic and half covalent. The covalent bonding comes mainly from (e1g) eta5-N5- --> Fe2+ pi-donation. The previously suggested MO correlation diagram for ferrocene is nicely recovered by the Kohn-Sham orbitals. The calculated vibrational frequencies and IR intensities are reported.
Collapse
Affiliation(s)
- M Lein
- Fachbereich Chemie, Philipps-Universität Marburg, Germany
| | | | | | | |
Collapse
|
48
|
Kreibich T, Lein M, Engel V, Gross EK. Even-harmonic generation due to beyond-Born-Oppenheimer dynamics. Phys Rev Lett 2001; 87:103901. [PMID: 11531478 DOI: 10.1103/physrevlett.87.103901] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/10/2001] [Indexed: 05/23/2023]
Abstract
We calculate the harmonic spectrum generated by a model HD molecule in a strong laser pulse. The unequal nuclear masses lead to the emission of even harmonics, i.e., photon frequencies which are even multiples of the laser frequency. The effect does not occur within the Born-Oppenheimer approximation. In the high-frequency region, the even harmonics are almost of the same order of magnitude as the odd ones.
Collapse
Affiliation(s)
- T Kreibich
- Institut für Theoretische Physik, Am Hubland, 97074 Würzburg, Germany
| | | | | | | |
Collapse
|
49
|
Jung K, Stephan C, Elgeti U, Lein M, Brux B, Kristiansen G, Rudolph B, Hauptmann S, Schnorr D, Loening SA, Sinha P. Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer? Int J Cancer 2001; 93:759-65. [PMID: 11477592 DOI: 10.1002/ijc.1393] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Molecular forms of prostate-specific antigen (PSA) improve the differentiation between benign prostatic hyperplasia (BPH) and prostate cancer (PCa) in men with total PSA concentrations between 4 and 10 microg/l. To evaluate the diagnostic utility of free PSA (fPSA) and complexed PSA forms for identification of men with PCa in the low PSA range of <4 microg/l, total PSA (tPSA), alpha(1)-antichymotrypsin complexed PSA (PSA-ACT) and fPSA (Roche Elecsys [ES] system) as well as tPSA and complexed PSA (cPSA) (Bayer Immuno 1 system) were measured in archival serum samples from 31 untreated patients with PCa, 66 patients with BPH, and 90 men without prostatic disease. The median ratios of fPSA/tPSA, PSA-ACT/tPSA and cPSA/tPSA were significantly different between patients with BPH and PCa (27.2 vs. 19.4%, 64 vs. 88%, 77.2 vs. 88.2%, p < 0.05). No associations between PSA forms and tumor stage and grade were found. Analysis of the receiver operating characteristic curves showed that these ratios could discriminate better between BPH and PCa patients than determination of the analytes tPSA, fPSA, cPSA and PSA-ACT alone. The use of one of the ratios would have eliminated roughly half of the unnecessary biopsies in this study. The ratios should be considered as potential tools to increase the selectivity of PCa detection at low PSA concentration. The ratios fPSA/tPSA and cPSA/tPSA can be determined using commercially available assays so that one of these ratios could be preferred instead of PSA-ACT determination. The ratios could be useful in assessing the risk of PCa in the individual and therefore in deciding on prostate biopsy for final diagnosis.
Collapse
Affiliation(s)
- K Jung
- Department of Urology, University Hospital Charité, Humboldt University, Berlin, Germany.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Lein M, Jung K, Hammerer P, Graefen M, Semjonow A, Stieber P, Ossendorf M, Luboldt HJ, Brux B, Stephan C, Schnorr D, Loening SA. A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis. Prostate 2001; 47:77-84. [PMID: 11340629 DOI: 10.1002/pros.1049] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
BACKGROUND The aim was to evaluate the clinical performance of alpha(1)-antichymotrypsin prostate-specific antigen (PSA-ACT) for early diagnosis of prostate cancer (PCa) in a multicenter trial. METHODS Three hundred sixty-seven white men with PCa and 290 with benign prostatic hyperplasia (BPH) with tPSA concentrations between 2 and 20 microg/L were analyzed. The Elecsys system 2010 (Roche Diagnostics, Germany) was used for determination of total PSA (tPSA) and free PSA (fPSA). The PSA-ACT test was a prototype assay used on the ES system (Roche Diagnostics). RESULTS The median concentrations of tPSA (PCa: 8.43 microg/L vs. BPH: 6.60 microg/L) and PSA-ACT (8.30 microg/L vs. 6.46 microg/L) were significantly different, respectively. The median ratios of fPSA/tPSA (PCa: 12% vs. BPH: 16%) and PSA-ACT/tPSA (98% vs. 95%) were significantly different. Receiver operating characteristics (ROC) analysis for discrimination between PCa and BPH (tPSA between 2 and 20 microg/L) was performed with 252 matched pairs and showed that the area under the curve (AUC) of the ratio fPSA/tPSA (0.66) was significantly different from tPSA (0.50) and PSA-ACT (0.52). PSA-ACT alone or the ratio PSA-ACT/tPSA (0.56) were not significantly different from tPSA. For tPSA between 4 and 10 microg/L (n = 145 pairs), the AUC of the ratio fPSA/tPSA (0.65) was significantly higher than tPSA (0.50) and PSA-ACT (0.54). Significant differences between tPSA and PSA-ACT or PSA-ACT/tPSA (0.56) were not found. CONCLUSIONS The determination of PSA-ACT as well as the PSA-ACT/tPSA ratio did not improve the diagnostic impact in patients undergoing evaluation for PCa compared to fPSA/tPSA ratio.
Collapse
Affiliation(s)
- M Lein
- Department of Urology, University Hospital Charité, Humboldt University, Berlin, Germany.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|